Zevra Therapeutics: Q1 Earnings Snapshot

Zevra Therapeutics, Inc. (ZVRA) on Thursday announced that its board has authorized a share repurchase program of up to $5 million of its common stock.


Celebration, Florida based company reported a loss per share of 34 cents.

The specialty pharmaceutical company reported revenue of $2.9 millions in the period.

This story was created by

Automated Insights



Zacks Investment Research data. Access to a

Zacks Stock Report on ZVRA

You can also check out our Facebook page.